PWA
ABBV icon

Peterson Wealth Advisors’s AbbVie ABBV Stock Holding History

Peterson Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$934K Buy
4,293
+12
+0.3% +$2.66K 0.12% 44
2025
Q4 		$978K Buy
4,281
+24
+0.6% +$5.47K 0.13% 44
2025
Q3 		$991K Buy
4,257
+7
+0.2% +$1.43K 0.15% 44
2025
Q2 		$789K Buy
4,250
+1
+0% +$186 0.13% 48
2025
Q1 		$793K Buy
4,249
+85
+2% +$16.5K 0.15% 41
2024
Q4 		$755K Sell
4,164
-45
-1% -$8.27K 0.14% 43
2024
Q3 		$831K Buy
4,209
+200
+5% +$37.3K 0.16% 37
2024
Q2 		$688K Buy
4,009
+30
+0.8% +$4.97K 0.14% 37
2024
Q1 		$725K Sell
3,979
-499
-11% -$86K 0.15% 36
2023
Q4 		$694K Buy
4,478
+45
+1% +$6.56K 0.16% 35
2023
Q3 		$661K Buy
4,433
+53
+1% +$7.78K 0.18% 33
2023
Q2 		$591K Buy
4,380
+54
+1% +$7.92K 0.16% 39
2023
Q1 		$689K Sell
4,326
-4
-0.1% -$612 0.19% 33
2022
Q4 		$700K Sell
4,330
-226
-5% -$34.7K 0.21% 32
2022
Q3 		$611K Sell
4,556
-59
-1% -$8.47K 0.21% 33
2022
Q2 		$707K Hold
4,615
– – 0.23% 28
2022
Q1 		$748K Buy
4,615
+391
+9% +$56.8K 0.22% 30
2021
Q4 		$572K Buy
4,224
+1,882
+80% +$222K 0.17% 40
2021
Q3 		$253K Hold
2,342
– – 0.08% 48
2021
Q2 		$264K Buy
2,342
+230
+11% +$25.9K 0.09% 48
2021
Q1 		$229K Hold
2,112
– – 0.09% 47
2020
Q4 		$226K Buy
+2,112
New +$203K 0.1% 44

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peterson Wealth Advisors's ABBV Position: Q1 2026 in Review

Peterson Wealth Advisors increased its AbbVie (ABBV) stake by 0.28% in Q1 2026, buying an estimated $2.66K and bringing the position to 4,293 shares worth $934K. The position accounts for 0.12% of the portfolio, ranked #44.

Peterson Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $991K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Peterson Wealth Advisors held 4,293 shares of AbbVie worth $934K as of Q1 2026.
  • Peterson Wealth Advisors bought 12 AbbVie shares in Q1 2026, an estimated $2.66K.
  • AbbVie made up 0.12% of Peterson Wealth Advisors's portfolio in Q1 2026, its #44 holding.
  • Peterson Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Peterson Wealth Advisors's AbbVie position peaked at $991K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Peterson Wealth Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.